Results
|
1.
|
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE). MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Eurointervention. 18(2):e132-e139, 2022 Jun 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Garcia-Garcia HM, Haner JD, Luscher TF, Moccetti M, Muller O, Raber L, Roffi M, Siegrist P, Stortecky S, Waksman R
|
|
2.
|
|
|
3.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
4.
|
Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus. MedStar authors:
- Kolm, Paul
- Lipinski, Michael J
- Shlofmitz, Evan
- Torguson, Rebecca
- Waksman, Ron
Year: 2019
Citation: - American Journal of Cardiology. 124(7):1020-1026, 2019 10 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Kandzari D, Kolm P, Koolen JJ, Lipinski MJ, Saito S, Shlofmitz E, Torguson R, Waksman R, Windecker S
|
|
5.
|
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. [Review] MedStar authors:
Year: 2021
Citation: - American Heart Journal. 235:140-148, 2021 05.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Asami M, Iglesias JF, Kandzari DE, Koolen J, Lefevre T, Muller O, Piccolo R, Pilgrim T, Rothenbuhler M, Saito S, Siontis GC, Slagboom T, Waksman R, Windecker S
|
|
6.
|
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. MedStar authors:
Year: 2013
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Meta-Analysis
All authors: - Andreotti F, Aprami TM, Claessen B, Di Pasquale G, Finn AV, Kandzari DE, Kedhi E, Kereiakes DJ, Kim HS, Kowalewski M, Kubica J, Mauri L, Meredith IT, Navarese EP, Suryapranata H, Tandjung K, von Birgelen C, Waksman R
|
|
7.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
8.
|
Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Clinical Therapeutics. 42(4):649-660.e9, 2020 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - BIOFLOW VI Trial Investigators, Gao R, Garcia-Garcia HM, Guan C, Han Y, Li C, Song D, Waksman R, Xu B, Xu J, Yang Y
|
|
9.
|
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors:
Year: 2013
Citation: - Eurointervention. 9(3):308-15, 2013 Jul.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R
|
|
10.
|
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. MedStar authors:
Year: 2015
Citation: - Circulation: Cardiovascular Interventions. 8(2):e001441, 2015 Feb.
Institution: - MedStar Heart & Vascular Institute
All authors: - Barragan P, Bilger J, Cook S, Erne P, Goicolea J, Haude M, Juni P, Lefevre T, Merkely B, Neumann FJ, Piot C, Richardt G, Sabate M, Schneider H, Slagboom T, Stangl K, Waksman R, Windecker S, Witzenbichler B, Zaugg S
|